181 related articles for article (PubMed ID: 16563972)
1. The cumulative effect of acute rejection on development of cardiac allograft vasculopathy.
Stoica SC; Cafferty F; Pauriah M; Taylor CJ; Sharples LD; Wallwork J; Large SR; Parameshwar J
J Heart Lung Transplant; 2006 Apr; 25(4):420-5. PubMed ID: 16563972
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy.
Sharples LD; Jackson CH; Parameshwar J; Wallwork J; Large SR
Transplantation; 2003 Aug; 76(4):679-82. PubMed ID: 12973108
[TBL] [Abstract][Full Text] [Related]
3. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.
Raichlin E; Edwards BS; Kremers WK; Clavell AL; Rodeheffer RJ; Frantz RP; Pereira NL; Daly RC; McGregor CG; Lerman A; Kushwaha SS
J Heart Lung Transplant; 2009 Apr; 28(4):320-7. PubMed ID: 19332257
[TBL] [Abstract][Full Text] [Related]
4. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
Delgado JF; Reyne AG; de Dios S; López-Medrano F; Jurado A; Juan RS; Ruiz-Cano MJ; Dolores Folgueira M; Gómez-Sánchez MÁ; Aguado JM; Lumbreras C
J Heart Lung Transplant; 2015 Aug; 34(8):1112-9. PubMed ID: 25940077
[TBL] [Abstract][Full Text] [Related]
5. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
[TBL] [Abstract][Full Text] [Related]
6. ACE2 and ACE in acute and chronic rejection after human heart transplantation.
Soler MJ; Batlle M; Riera M; Campos B; Ortiz-Perez JT; Anguiano L; Roca-Ho H; Farrero M; Mont L; Pascual J; Perez-Villa F
Int J Cardiol; 2019 Jan; 275():59-64. PubMed ID: 30314840
[TBL] [Abstract][Full Text] [Related]
7. Early aspirin use and the development of cardiac allograft vasculopathy.
Kim M; Bergmark BA; Zelniker TA; Mehra MR; Stewart GC; Page DS; Woodcome EL; Smallwood JA; Gabardi S; Givertz MM
J Heart Lung Transplant; 2017 Dec; 36(12):1344-1349. PubMed ID: 28781013
[TBL] [Abstract][Full Text] [Related]
8. Follow-up of heart transplant recipients with serial echocardiographic coronary flow reserve and dobutamine stress echocardiography to detect cardiac allograft vasculopathy.
Sade LE; Eroğlu S; Yüce D; Bircan A; Pirat B; Sezgin A; Aydınalp A; Müderrisoğlu H
J Am Soc Echocardiogr; 2014 May; 27(5):531-9. PubMed ID: 24613313
[TBL] [Abstract][Full Text] [Related]
9. Predicting the development of cardiac allograft vasculopathy.
Seki A; Fishbein MC
Cardiovasc Pathol; 2014; 23(5):253-60. PubMed ID: 24972526
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen G single-nucleotide polymorphism -201 (CC-CC) donor-recipient genotype matching as a predictor of severe cardiac allograft vasculopathy.
Lazarte J; Goldraich L; Manlhiot C; Billia F; Ross H; Rao V; Delgado D
J Heart Lung Transplant; 2016 Sep; 35(9):1101-7. PubMed ID: 27287629
[TBL] [Abstract][Full Text] [Related]
11. Quantitative myocardial contrast echocardiography: a new method for the non-invasive detection of chronic heart transplant rejection.
Rutz T; de Marchi SF; Roelli P; Gloekler S; Traupe T; Steck H; Eshtehardi P; Cook S; Vogel R; Mohacsi P; Seiler C
Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1187-94. PubMed ID: 23612502
[TBL] [Abstract][Full Text] [Related]
12. Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous intervention.
Agarwal S; Parashar A; Kapadia SR; Tuzcu EM; Modi D; Starling RC; Oliveira GH
JACC Heart Fail; 2014 Jun; 2(3):281-8. PubMed ID: 24952696
[TBL] [Abstract][Full Text] [Related]
13. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study.
Loupy A; Coutance G; Bonnet G; Van Keer J; Raynaud M; Aubert O; Bories MC; Racapé M; Yoo D; Duong Van Huyen JP; Bruneval P; Taupin JL; Lefaucheur C; Varnous S; Leprince P; Guillemain R; Empana JP; Levine R; Naesens M; Patel JK; Jouven X; Kobashigawa J
Circulation; 2020 Jun; 141(24):1954-1967. PubMed ID: 32363949
[TBL] [Abstract][Full Text] [Related]
14. Association of acidic fibroblast growth factor and untreated low grade rejection with cardiac allograft vasculopathy.
Zhao XM; Citrin BS; Miller GG; Frist WH; Merrill WH; Fischell TA; Atkinson JB; Yeoh TK
Transplantation; 1995 Apr; 59(7):1005-10. PubMed ID: 7535956
[TBL] [Abstract][Full Text] [Related]
15. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium.
Hosenpud JD; Everett JP; Morris TE; Mauck KA; Shipley GD; Wagner CR
Circulation; 1995 Jul; 92(2):205-11. PubMed ID: 7600652
[TBL] [Abstract][Full Text] [Related]
16. Heart Transplantation and Risk of Cardiac Vasculopathy Development: What Factors Are Important?
Sobieszczańska-Małek M; Korewicki J; Komuda K; Karczmarz M; Szymańska S; Cicha-Mikołajczyk A; Bekta P; Parulski A; Pronicki M; Grajkowska W; Małek G; Leszek P; Kaczorowska M; Kuśmierczyk M; Zieliński T
Ann Transplant; 2017 Nov; 22():682-688. PubMed ID: 29146891
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
[TBL] [Abstract][Full Text] [Related]
18. Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation.
Tremblay-Gravel M; Racine N; de Denus S; Ducharme A; Pelletier GB; Giraldeau G; Liszkowski M; Parent MC; Carrier M; Fortier A; White M
JACC Heart Fail; 2017 Dec; 5(12):891-901. PubMed ID: 29191295
[TBL] [Abstract][Full Text] [Related]
19. Cardiac allograft vasculopathy: Incidence and predictors in a single-center cohort.
Picão S; Oliveira-Santos M; Batista M; Prieto D; Antunes MJ; Pego M; Matos V; Gonçalves L; Jorge E
Rev Port Cardiol (Engl Ed); 2020 Apr; 39(4):205-212. PubMed ID: 32471665
[TBL] [Abstract][Full Text] [Related]
20. Cardiac allograft vasculopathy: a donor or recipient induced pathology?
van den Hoogen P; Huibers MM; Sluijter JP; de Weger RA
J Cardiovasc Transl Res; 2015 Mar; 8(2):106-16. PubMed ID: 25652948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
